• Pharmacology
  • Allergy, Immunology, and ENT
  • Cardiology
  • Emergency Medicine
  • Endocrinology
  • Adolescent Medicine
  • Gastroenterology
  • Infectious Diseases
  • Neurology
  • OB/GYN
  • Practice Improvement
  • Gynecology
  • Respiratory
  • Dermatology
  • Mental, Behavioral and Development Health
  • Oncology
  • Rheumatology
  • Sexual Health
  • Pain

FDA warns of Botox deaths in children

Article

The Food and Drug Administration (FDA) released a warning saying that botulism toxin can be lethally dangerous.

The Food and Drug Administration (FDA) released a warning saying that botulism toxin can be lethally dangerous.

The poison is used in adulterated doses as wrinkle-removers such as Botox and Myobloc, where it paralyses muscles. The agents are also used off-label in the US, and by indication in other countries, to stop tremors in cerebral palsy patients.

But the muscle paralysis can, in rare cases, go beyond the injected muscle, affecting the crucial muscles needed to breathe and swallow. A small number of people, all children, have died after receiving botulism toxin as therapy.

Advocacy group Public Citizen started a petition two weeks ago to increase the warnings on Botox and Myobloc, saying that over 180 people had adverse reactions. It is pushing for a black-box warning on the agents, which they do not currently have.

Related Videos
Natasha Hoyte, MPH, CPNP-PC
Lauren Flagg
Venous thromboembolism, Heparin-induced thrombocytopenia, and direct oral anticoagulants | Image credit: Contemporary Pediatrics
Jessica Peck, DNP, APRN, CPNP-PC, CNE, CNL, FAANP, FAAN
Sally Humphrey, DNP, APRN, CPNP-PC | Image Credit: Contemporary Pediatrics
Ashley Gyura, DNP, CPNP-PC | Image Credit: Children's Minnesota
Congenital heart disease and associated genetic red flags
Traci Gonzales, MSN, APRN, CPNP-PC
© 2024 MJH Life Sciences

All rights reserved.